Jill and Joe Biden are going through one of the toughest phases of their lives. Just days ago, the former president was ...

In a post-hoc analysis from the Phase III ARANOTE trial, new results show metastatic castration-sensitive prostate cancer ...

A new treatment approach is giving men with advanced prostate cancer more years to live.

The diagnosis came after he experienced urinary symptoms and underwent medical evaluation. His Gleason score of 9 indicates a high-grade cancer, but doctors say it is hormone-sensitive and potentially ...

Despite these clinical milestones and ongoing innovation, including first-in-human studies of new oncology drugs, Pfizer Inc.

Manhattan internist Dr Stuart Fischer recently weighed in on Joe Biden's Gleason score 9 prostate cancer diagnosis ...

Astellas & Pfizer’s Xtandi shows long-term overall survival in metastatic hormone-sensitive prostate cancer: Tokyo Saturday, May 24, 2025, 13:00 Hrs [IST] Astellas Pharma Inc. a ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...

Here’s what you should know about PSA screening, why medical guidelines vary and why individualized approaches are essential ...

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.

Five- and eight-year trial data to be presented at ASCO demonstrate durable survival outcomes with Xtandi (enzalutamide) plus ...

The idea that a man could receive regular exams and still wind up with a late-stage discovery? It doesn’t surprise me at all.